Stocks With the Highest Consensus of Expected ROE Growth, Goldman Sachs Says
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
J&J Releases Encouraging Data on Talvey Combination Therapies
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Hurricane Helene Update: 28 Dead, Power Outages, Insurance Damages And More
Amazon Prime Day Data Insights Before October Event: Apple Purchases Up 22%, Celsius Tops Grocery Category
Bristol-Myers Squibb Analyst Ratings
Today's Pre-Market Movers and Top Ratings | COST, DG, BMBL, HPQ and More
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Biggest Stock Movers Friday: BB, BMY, and More
Bristol-Myers Wins FDA Nod for First-of-its-kind Antipsychotic
Merck, Bristol-Myers Fail to Convince FDA AdCom on Wider Opdivo, Keytruda Use
Hurricane Helene Disrupts Flights, Sports Events, Disney Operations: Affected Regions, Stocks To Watch
How Is The Market Feeling About Altria Group?
Florida Braces for Hurricane Helene, Energy Infrastructure in Storm's Path at Risk
Here's How Much $1000 Invested In Travelers Companies 20 Years Ago Would Be Worth Today
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
Google Cloud Outlook Appears Rosy on Gen AI Offerings: Wedbush
Duke Energy Analyst Ratings
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability